Status:
COMPLETED
Comparison of Tacrolimus 0.1% and Clobetasol 0.05% in the Management of Symptomatic Oral Lichen Planus
Lead Sponsor:
University of Peradeniya
Conditions:
Oral Lichen Planus
Eligibility:
All Genders
20-70 years
Phase:
PHASE2
Brief Summary
This clinical study is carried out to assess the efficacy of Tacrolimus and Clobetasol in symptomatic Oral Lichen Planus.
Eligibility Criteria
Inclusion
- Clinically and Histologically proven Oral Lichen Planus
- Symptomatic
Exclusion
- topical/ systemic medication for OLP in the previous three months
- contraindication for medications use such as a history of allergy to either corticosteroids/ tacrolimus
- immunosuppression, or pregnant / lactating females
- lichenoid reactions either drug induced or due to dental amalgam
- diabetes mellitus and on oral hypoglycemic drugs
- systemic involvement such as concurrent skin/genital lesions
Key Trial Info
Start Date :
June 1 2014
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2015
Estimated Enrollment :
68 Patients enrolled
Trial Details
Trial ID
NCT02744378
Start Date
June 1 2014
End Date
December 1 2015
Last Update
April 20 2016
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.